Skip to search formSkip to main contentSkip to account menu
Inhibition of enterotoxin-induced porcine colonic secretion by diarylsulfonylureas in vitro.
TLDR
DASUs compose a family of inhibitors that may be of therapeutic value for the symptomatic treatment of diarrhea resulting from a broad spectrum of causative agents across species, as indicated by the structure- and concentration-dependent inhibition shown.
View on PubMed
Myeloma bone disease: pathogenesis and treatment.
TLDR
Novel agents targeting OBD are promising therapeutic strategies not only for the treatment of MM OBD but also for the Treatment of MM itself, and several novel agents are currently under investigation for their positive effect on bone remodeling via osteoclast inhibition or osteoblast stimulation.
View on PubMed
A new treatment for neonatal scours
TLDR
In the present study, a variety of prospective drugs were used to determine if a single compound might inhibit the effects of bacterial toxins in a laboratory setting and results indicate that a new class of drugs, which the authors call DASUs, likely will prove useful for the treatment of watery diarrhea.
View PDF
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License